Tus kws kho mob
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2611 - 2620 ntawm 3590
Tus kws kho mob
P5R2-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P18-21 New Reimbursement Policy for Minnesota Health Care Programs Modifier 90: Reference (Outside) Laboratory and Pass-Through Billing
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P11R1-21 UPDATE: Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P19-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P16-21 Genetic/Molecular Lab Test Coding Reimbursement Policy for MHCP
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
2021 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P17-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P15-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective May 31, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
QP22-21 Commercial and MHCP Pharmacy Benefit Exclusion for Nulibry™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 24, 2021